Search research articles
Contact Us
Filters
Showing results (91-100 of 247) with videos related to
Page
of 25
Sort By:
Breast Cancer Research : BCR
|
March 4, 2024
A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer
Jordi Rodón, David Demanse, Hope S Rugo, et al.
Cancer Investigation
|
February 18, 2010
Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium
John D Hainsworth, Anthony A Meluch, Cassie M Lane, et al.
Clinical Advances in Hematology & Oncology : H&O
|
April 9, 2011
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors
Suzanne F Jones, Johanna C Bendell, Jeffrey R Infante, et al.
Cancer Chemotherapy and Pharmacology
|
June 1, 2011
A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine
Jeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
A phase I study of sunitinib plus capecitabine in patients with advanced solid tumors
Christopher J Sweeney, E Gabriela Chiorean, Claire F Verschraegen, et al.
Clinical Breast Cancer
|
November 26, 2009
A phase II randomized crossover study of liposomal doxorubicin versus weekly docetaxel in the first-line treatment of women with metastatic breast cancer
Denise A Yardley, Howard A Burris, David R Spigel, et al.
Journal of Clinical Pharmacology
|
September 29, 2011
Clinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer
Manish Gupta, Patricia M Lorusso, Bei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study
F Anthony Greco, Howard A Burris, Sharlene Litchy, et al.
The Oncologist
|
October 27, 2005
Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial
F Anthony Greco, Dana S Thompson, Lisa H Morrissey, et al.
The Oncologist
|
November 25, 2004
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial
F Anthony Greco, Gladys I Rodriguez, Don W Shaffer, et al.
Page
of 25
Search research articles
Search
Showing results (91-100 of 247) with videos related to
Sort By:
Page
of 25
Breast Cancer Research : BCR
|
March 4, 2024
A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer
Jordi Rodón, David Demanse, Hope S Rugo, et al.
Cancer Investigation
|
February 18, 2010
Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium
John D Hainsworth, Anthony A Meluch, Cassie M Lane, et al.
Clinical Advances in Hematology & Oncology : H&O
|
April 9, 2011
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors
Suzanne F Jones, Johanna C Bendell, Jeffrey R Infante, et al.
Cancer Chemotherapy and Pharmacology
|
June 1, 2011
A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine
Jeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
A phase I study of sunitinib plus capecitabine in patients with advanced solid tumors
Christopher J Sweeney, E Gabriela Chiorean, Claire F Verschraegen, et al.
Clinical Breast Cancer
|
November 26, 2009
A phase II randomized crossover study of liposomal doxorubicin versus weekly docetaxel in the first-line treatment of women with metastatic breast cancer
Denise A Yardley, Howard A Burris, David R Spigel, et al.
Journal of Clinical Pharmacology
|
September 29, 2011
Clinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer
Manish Gupta, Patricia M Lorusso, Bei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study
F Anthony Greco, Howard A Burris, Sharlene Litchy, et al.
The Oncologist
|
October 27, 2005
Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial
F Anthony Greco, Dana S Thompson, Lisa H Morrissey, et al.
The Oncologist
|
November 25, 2004
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial
F Anthony Greco, Gladys I Rodriguez, Don W Shaffer, et al.
Page
of 25